Learn about Huateng's latest developments, industry news, and research findings
In the complex journey of drug discovery and biomedical research, the transition from the bench to human clinical trials is the most precarious stage of preclinical development. For pharmaceutical companies, selecting the right animal model is not just a regulatory box to check; it is a critical mission to validate the safety of promising drug candidates.
Learn how guinea pig models support immunology, respiratory disease, vaccine development, and ISO 10993 medical device testing. HuaTeng Biotechnology provides expert CRO guinea pig studies, including respiratory disease models, biocompatibility testing, cochlear implant surgery, and vaccine safety assays.
Explore the strategic value of mouse and rat models in biomedical research and preclinical drug development. Learn how genetically engineered models, humanized mice, and specialized in vivo applications support IND-enabling studies in oncology, metabolic disease, and behavioral neuroscience at HuaTeng Biotechnology.
Rabbit models in biomedical research, specifically the New Zealand White (NZW) and the Watanabe Heritable Hyperlipidemic (WHHL) rabbit, serve as a sophisticated biological bridge. They connect early-stage laboratory animal testing to the ultimate goal: human clinical trials.
Explore the critical role of canine models in IND-enabling studies and medical device evaluation. From heart disease research to surgical implants, learn how Beagle research models provide high-fidelity data for human clinical trials. Partner with HuaTeng’s expert canine CRO services to ensure the safety and efficacy of your drug candidates and medical devices in the United States and globally.
Explore why non-human primates (NHPs) are indispensable in preclinical drug development. This guide details their role in complex toxicity testing, biologics evaluation, & long-term safety studies, ensuring drug efficacy & regulatory success.
The sheep model, formally known as the ovine model, has become a preferred choice for advanced preclinical testing. Its established predictive value makes it a mainstay in the development pipelines of major pharmaceutical companies and top research institutions internationally.
Pigs are becoming an increasingly essential animal model in biomedical research due to their anatomical and physiological similarities to humans. This makes them invaluable for studying human disease, testing medical devices, and developing treatments. In this guide, we will explore why pig models are pivotal in preclinical research, how they are used across various medical fields, and important considerations for researchers utilizing these animal models for medical devices.
Animal models are critical for assessing how a device interacts with living tissues and how it performs in real-world biological conditions. This article explains how animal models support device testing, how they meet medical device regulations, and why they are essential for ensuring safety and performance in the long term.
HuaTeng provides an overview of how to select the appropriate animal model at each stage of the drug development process, what factors to consider, and why specific models are more effective in certain applications.If you're unsure which animal model to choose, need guidance on designing IND-enabling studies, or want tips on accelerating clinical development, our expert scientists at HuaTeng are here to help.
In biomedical research, selecting the right model is a fundamental aspect of scientific research and can be the key to a successful study, whether for pharmaceuticals or medical devices. This article will walk you through the most common types of animal models, their ideal use cases, and essential factors to consider when choosing the right model for your research, helping you improve both reproducibility and translational success.
HuaTeng explore the role of CDX and syngeneic tumor models in preclinical cancer research. Learn how xenograft models using immunodeficient mice help evaluate chemotherapy and targeted therapies, while syngeneic models in immunocompetent mice support immuno-oncology discovery. Accelerate your drug development pipeline with validated in vivo platforms.